Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Ayurvedic researchers find aid to disease management
A team of two researchers — an ayurvedic physician and a retired senior scientist of the Central Food Technological Research Institute — have discovered some beneficial properties of cow urine after about 18 months of research in a private analytical laboratory in Mysore. Meanwhile, a homeopathy practitioner, has claimed that it could help cure the influence caused by H1N1 virus too.

No pay hike for British queen
Like many, Britain’s queen will also not get a pay hike, at least till elections next year. According to the Daily Express, British Prime Minister Gordon Brown has told the queen, she will have to wait until after the general elections to discuss her bid for a rise in her £7.9 million a year Civil List payment. Brown has decided not to fix a new 10-year deal covering the queen’s costs, fearing that the plea for a huge pay rise over the next 10 years could become an election issue, the report said.

News of the day

States' panel to prepare rules for land banks
The Centre today constituted a committee of industry ministers of seven states to prepare guidelines for creating land banks for meeting industrial needs.
Online Business

Novartis says produces first batch of H1N1 vaccine

Swiss pharmaceuticals company Novartis AG said today it has successfully produced a first batch of swine flu vaccine weeks ahead of expectations. - Zydus Cadila files anti-diabetic drug application with DCGI - Glenmark gets US regulatory nod for anti-hypertension tablets - Taro acquisition may cost Sun Pharma Rs 1,000 cr - Sun Pharma FY"09 net up 22 % at Rs 1,817.73 cr - Wockhardt appoints BDO Haribhakti as auditor - Aurobindo Phrama gets USFDA nod for veterinary drug The vaccine was made in cells, rather than grown in eggs as is usually the case with vaccines, the company said. The announcement comes a day after the World Health Organisation declared swine flu, also known as A(H1N1), a pandemic. The move indicates that a global outbreak is under way. WHO says drugmakers will likely have vaccines approved and ready for sale after September. Novartis said it would use the first batch of vaccine for pre-clinical evaluation and testing. It is also being considered for clinical trials, the company said. The vaccine was produced at a Novartis plant in Marburg, Germany. Novartis said the facility could potentially produce millions of doses of vaccine a week. A second plant is being built in Holly Springs, North Carolina, the company said. Novartis said more than 30 governments have requested vaccine supplies, including the US Department of Health and Human Service, which placed a $289 million order in May.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009